Research Topics
| Gregor K WenningSummaryAffiliation: Innsbruck Medical University Country: Austria Publications
| Collaborators
|
Detail Information
Publications
The natural history of multiple system atrophy: a prospective European cohort studyGregor K Wenning
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Lancet Neurol 12:264-74. 2013..Here we present the final analysis of a prospective multicentre study by the European MSA Study Group to investigate the natural history of MSA...
Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative studyGregor Karl Wenning
Autonomic Unit, Division of Clinical Neurobiology, Department of Neurology, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
Cerebellum 11:223-6. 2012..Differences in brainstem pathology are likely to account for the tight association of MSA-C and OH. A simple standing test should be obligatory in the work-up of patients with sporadic late-onset ataxias...
Recent developments in multiple system atrophyGregor K Wenning
Section of Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
J Neurol 256:1791-808. 2009..An outline of the rationale for managing symptomatic deterioration in MSA is provided together with a summary of novel experimental therapeutic approaches to decrease disease progression...
Milestones in atypical and secondary ParkinsonismsGregor K Wenning
Division of Clinical Neurobiology, Department of Neurology, Medical University, Innsbruck, Austria
Mov Disord 26:1083-95. 2011..Early-investigation-assisted clinical diagnosis has become more crucial than ever because disease-modifying therapies will hopefully become available within this decade...
Multiple system atrophy: a primary oligodendrogliopathyGregor K Wenning
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Ann Neurol 64:239-46. 2008..Although these syndromes vary in their respective cause of oligodendrogliopathy, they have in common myelin disruption that is often followed by axonal dysfunction...
New insights into atypical parkinsonismGregor K Wenning
Department of Neurology, Medical University, Innsbruck, Austria
Curr Opin Neurol 24:331-8. 2011..Based on literature published in 2010, we here review recent advances in the APD field...
Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's diseaseChristoph Scherfler
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Brain 128:1605-12. 2005..We suggest that the quantification of midbrain DAT signal should be included in the routine clinical analysis of [123I]beta-CIT SPECT in patients with uncertain parkinsonism...
Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophyNadia Stefanova
Clinical Neurobiology Unit, Neurodegeneration Research Laboratory, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 22:2196-203. 2007....
Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR studyKlaus Seppi
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Neuroimage 31:240-5. 2006....
Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry studyChristian Brenneis
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 21:159-65. 2006..We observed a volume loss shared by both disorders comprising the cerebellum, vermis, pons, mesencephalon, orbitofrontal, mid-frontal, and temporomesial cortex of both hemispheres as well as the left insular cortex...
Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa responseMartin Köllensperger
Section for Clinical Neurobiology, Innsbruck Medical University, Innsbruck, Austria
J Neurosci Res 87:1679-85. 2009..Therefore, striatal transplantation should be further defined preclinically as a possible therapeutic option for patients with MSA-P and a failing L-Dopa response...
Diffusion-weighted imaging in Huntington's diseaseKlaus Seppi
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 21:1043-7. 2006..Diffusion-weighted imaging appears to be a promising surrogate marker for disease severity in HD. Sensitivity to change remains to be established longitudinally...
Red flags for multiple system atrophyMartin Köllensperger
Section for Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Austria
Mov Disord 23:1093-9. 2008..9 (+/-7.0) months earlier than with the Consensus criteria alone. We propose a combination of two out of six red flag categories as additional diagnostic criteria for probable MSA-P...
Rasagiline is neuroprotective in a transgenic model of multiple system atrophyNadia Stefanova
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Exp Neurol 210:421-7. 2008..5 mg/kg rasagiline. The results of the study indicate that rasagiline confers neuroprotection in a transgenic mouse model of MSA and may therefore be considered a promising disease-modifying candidate for human MSA...
Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]beta-CIT SPECT analysisChristoph Scherfler
Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
Eur J Nucl Med Mol Imaging 33:1084-90. 2006..To this end, nine patients were studied with [(123)I]beta-CIT SPECT...
Restless legs syndrome in Parkinson's diseaseCecilia M Peralta
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 24:2076-80. 2009..7 years). The majority (n = 17, 61%) who scored positive for RLS reported that the urge to move the legs and unpleasant sensations were associated with wearing off, raising the possibility of RLS mimics in fluctuating patients with PD...
Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in ratsChristoph Scherfler
Clinical Department of Neurology, Innsbruck Medical University, 6020 Innsbruck, Austria
Neuroimage 24:822-31. 2005..SPECT-MRI-based estimation of regional [123I]IBZM uptake provides a cost effective and widely available in vivo imaging technique for assessing striatal integrity in animal studies...
Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophyMartin Köllensperger
Clinical Department of Neurology, Innsbruck Medical University, Austria
Mov Disord 22:353-8. 2007..593; P = 0.01) in the stepping test. These findings contribute further to the behavioral characterization of the double lesion rat model of MSA, improving its value in the evaluation of future neurorestorative strategies...
Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophyMartin Köllensperger
Division of Clinical Neurobiology, Department of Neurology, Medical University, Innsbruck, Austria
Mov Disord 26:507-15. 2011..This effect is associated with improved motor function. Further studies are warranted to develop erythropoietin as a potential interventional therapy in multiple system atrophy...
Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophyChristine Kaindlstorfer
Neurological Research Laboratory, University Hospital, Innsbruck, Austria
J Neurosci Res 90:1284-95. 2012..In summary, we have established the behavioral deficit profile of a partial double-lesion rat model mimicking the early stage of MSA-P...
Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy)Laura Mantoan
Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria
Acta Neuropathol (Berl) 109:191-7. 2005....
Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphyMartin Köllensperger
Clinical Department of Neurology, Innsbruck Medical University, Austria
Mov Disord 22:1771-6. 2007..6% vs. 100%, specificity 88.8% vs. 100%, and area under the curve 0.802 vs. 1.000. Our data suggest that DWI is superior to both tilt table testing and MIBG scintigraphy in the differential diagnosis of PD versus MSA-P...
The Unified Multiple System Atrophy Rating Scale: intrarater reliabilityFlorian Krismer
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 27:1683-5. 2012..In the present study, the intrarater agreement of the motor examination part of the UMSARS was determined...
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)Felix Geser
Clinical Department of Neurology, Innsbruck Medical University, Austria
Mov Disord 21:179-86. 2006..Our data contribute to the ongoing validation process of UMSARS, and they facilitate the planning and implementation of future neuroprotective intervention trials...
Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophyNadia Stefanova
Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35 A 6020, Innsbruck, Austria
Am J Pathol 166:869-76. 2005..Our results indicate that combined mitochondrial inhibition and overexpression of oligodendroglial alpha-SYN generates a novel model of MSA that may be useful for evaluating both pathogenesis and treatment strategies...
Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's diseaseChristoph Scherfler
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Brain 129:538-42. 2006..Whether DWI can be used as a marker to identify individuals at risk to develop this disease remains to be shown...
Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysisKlaus Seppi
Department of Neurology, Medical University Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
Arch Neurol 63:1154-60. 2006..Most previous SPECT studies have adopted region-of-interest methods for analysis, which are subjective and operator dependent...
Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance studyKlaus Seppi
Department of Neurology, Innsbruck Medical University, Austria
Mov Disord 21:847-52. 2006..Our study demonstrates prominent involvement of the posterior putamen in early disease stages of MSA-P in vivo by assessing putaminal diffusivity with the help of DWI...
Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's diseaseChristoph Scherfler
Department of Neurology, Innsbruck, Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
Brain 135:3348-54. 2012....
How to diagnose dementia with Lewy bodies: state of the artFelix Geser
Clinical Department of Neurology, Medical University Innsbruck, Austria
Mov Disord 20:S11-20. 2005..We review the present state of the best practice in the clinical diagnosis of DLB. Future modifications of diagnostic criteria would ideally include the full range of clinical presentations that can be associated with LB disease...
A novel computer-assisted image analysis of [123I]β-CIT SPECT images improves the diagnostic accuracy of parkinsonian disordersGeorg Goebel
Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Schöpfstrasse 41 2, A 6020, Innsbruck, Austria
Eur J Nucl Med Mol Imaging 38:702-10. 2011....
Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imagingSylvia M Boesch
Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
J Magn Reson Imaging 25:564-9. 2007..To assess and compare biochemical and volumetric features of the cerebellum in patients with spinocerebellar ataxia type 2 (SCA2) and patients with the cerebellar variant of multiple system atrophy (MSA-C)...
Striatal transplantation for multiple system atrophy--are grafts affected by alpha-synucleinopathy?Nadia Stefanova
Department of Clinical Neurobiology, Innsbruck Medical University, Innsbruck, Austria
Exp Neurol 219:368-71. 2009..Our data suggest that the presence of MSA-like alpha-synuclein oligodendrogliopathy and related to it pro-inflammatory microenvironment may compromise the connectivity and neurorestorative outcome of striatal grafts...
Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophyZoe Puschban
Experimental Neurodegeneration Laboratory, Department of Neurology, University Hospital Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
Brain Res Bull 68:54-8. 2005..e. early stage disease with limited striatal dysfunction...
Voxel based morphometry reveals specific gray matter changes in primary dystoniaKarl Egger
Department of Radiology, Innsbruck Medical University, Austria
Mov Disord 22:1538-42. 2007..This is the first study using VBM in patients with different types of primary dystonia, showing a common pattern of gray matter changes...
Restless legs syndrome and motor activity during sleep in spinocerebellar ataxia type 6Sylvia M Boesch
Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
Sleep Med 7:529-32. 2006..None of the patients had REM sleep behaviour disorder. Only one patient had mild REM sleep without atonia. CONCLUSIONS: Our pilot study suggests only minor sleep abnormalities in SCA6...
Progression of brain atrophy in multiple system atrophy. A longitudinal VBM studyChristian Brenneis
Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
J Neurol 254:191-6. 2007..The UPDRS-III score was not significantly correlated with any brain region. Our data suggest that cortical atrophy is prominent in MSA-P and early degeneration of the basal ganglia drives late onset cortical atrophy...
In vitro models of multiple system atrophyNadia Stefanova
Neurological Research Laboratory, Department of Neurology, University Hospital of Innsbruck, Austria
Mov Disord 20:S53-6. 2005..With this simplified system, we have demonstrated that alpha-synuclein significantly affects the survival of glia and its vulnerability to environmental stress, which might represent a major step in the pathogenesis of MSA...
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registryMartin Köllensperger
Clinical Department of Neurology, Innsbruck Medical University, Austria
Mov Disord 25:2604-12. 2010..The observed differences in diagnostic and therapeutic management including lack of therapy for dysautonomia emphasize the need for future guidelines in these areas...
Levodopa-induced sleepiness in the Parkinson variant of multiple system atrophyKlaus Seppi
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 21:1281-3. 2006..These findings suggest greater potential of levodopa to induce sleepiness in MSA compared with PD, which may be related to differences in basal ganglia and brainstem pathology between the two disorders...
Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophyWolfgang N Löscher
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 22:174-8. 2007..We suggest that these abnormalities reflect the motor cortex pathology found in MSA-P...
Progression of parkinsonism in multiple system atrophyKlaus Seppi
Department of Neurology, University Hospital, Innsbruck, Austria
J Neurol 252:91-6. 2005..Furthermore, motor progression appeared to be accelerated during the early disease stages.Our data allow sample size calculations that may be helpful for the planning of future therapeutic trials...
Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophyNadia Stefanova
Division of Neurobiology, Innsbruck Medical University, Innsbruck, Austria
Acta Neuropathol 124:51-65. 2012..In summary, we provide new evidence supporting a primary role of proteolytic failure and suggesting a neurodegenerative pathomechanism related to disturbed oligodendroglial/myelin trophic support in the pathogenesis of MSA...
Freezing of gait in postmortem-confirmed atypical parkinsonismJörg Müller
Department of Neurology, University Hospital Innsbruck, Austria
Mov Disord 17:1041-5. 2002..Whether FoG and urinary incontinence share similar neuropathological substrates remains to be determined by future studies...
Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I]β-CIT SPECTMichael Nocker
Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
Eur J Nucl Med Mol Imaging 39:1012-20. 2012....
Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failureSylvia Stemberger
Division of Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Exp Neurol 224:459-64. 2010....
Midbrain sonography in patients with essential tremorHeike Stockner
Department of Neurology, Medical University Innsbruck, Austria
Mov Disord 22:414-7. 2007..These findings might correspond to an increased risk of ET patients to develop PD. Long-term follow-up will show if those with hyperechogenic SN develop PD, while these without will not...
Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophyChristian Brenneis
Department of Neurology, University Hospital, Innsbruck, Austria
Mov Disord 18:1132-8. 2003..Further studies are required to determine clinical and/or subclinical correlates of cortical atrophy in MSA-P...
Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based studyGregor K Wenning
Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
Lancet Neurol 4:815-20. 2005..A fifth of all movement disorders were diagnosed to be probably drug-induced. INTERPRETATION: There is a high prevalence of and substantial under-recognition and under-treatment of movement disorders in the general community...
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)Gregor K Wenning
Department of Neurology, University of Innsbruck, Austria
Mov Disord 19:1391-402. 2004..Based on our findings, the UMSARS appears to be a multidimensional, reliable, and valid scale for semiquantitative clinical assessments of MSA patients...
Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neuronsNadia Stefanova
Division of Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Am J Pathol 179:954-63. 2011..The study supports TLR4 signaling as innate neuroprotective mechanism acting through clearance of α-synuclein...
Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's diseaseKlaus Seppi
Department of Neurology, University of Innsbruck, Innsbruck, Austria
Mov Disord 19:1438-45. 2004..Striatal rADCs had a significant higher overall predictive accuracy than D2R binding with IBZM. In summary, our data suggest that DWI may be more accurate compared to IBZM-SPECT in the differential diagnosis of MSA-P versus PD...
Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2Sylvia M Boesch
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 21:1751-4. 2006..Abnormal motor control during sleep with periodic leg movements and REM sleep without atonia occurs frequently in SCA2. This finding may reflect a dysfunction of dopaminergic and/or brainstem and cerebellar outflow pathways...
Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degenerationNadia Stefanova
Neurodegeneration Research Laboratory, Innsbruck MSA Study Group, Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
J Neurosci Res 78:87-91. 2004..We conclude that despite its astrocytic and microglial suppression, minocycline failed to attenuate lesion-induced neuronal damage in the SND rat model...
Therapeutic strategies in multiple system atrophyGregor K Wenning
Innsbruck Medical University, Clinical Department of Neurology, Austria
Mov Disord 20:S67-76. 2005..Because no drug treatment consistently benefits patients with this disease in the long-term, palliative therapies are all the more important. Novel symptomatic and neuroprotective therapies are urgently required...
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astrogliaLisa Fellner
Division of Neurobiology, Innsbruck Medical University, Austria
Glia 61:349-60. 2013..Our data provide novel insights into the mechanisms of α-synuclein-induced microglial and astroglial activation which may have an impact on understanding the pathogenesis of ASP...
Auditory startle response in cervical dystoniaJörg Müller
Department of Neurology, University Hospital Innsbruck, Innsbruck, Austria
Mov Disord 18:1522-6. 2003..Reduced ASR probability and magnitude as well as prolonged EMG activity after the proper startle response corroborate and extend previous findings on brainstem dysfunction in CD...
Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse modelNadia Stefanova
Division of Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Anichstr 35, 6020 Innsbruck, Austria
Neurotox Res 21:393-404. 2012..This study suggests that MPO inhibition may represent a novel candidate treatment strategy against MSA-like neurodegeneration acting through its anti-inflammatory and anti-oxidative properties...
Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT studySylvia M Boesch
Department of Neurology, University of Innsbruck, Austria
Mov Disord 19:1320-5. 2004..Both slowness of limb movements as well as dystonia in the ataxic SCA2 phenotype may reflect dysfunction not only at cerebellar but also at basal ganglia level...
Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotectionSylvia Stemberger
Divison of Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
PLoS ONE 6:e19808. 2011..In this study we investigated the efficacy of intravenously applied MSCs in terms of behavioural improvement, neuroprotection and modulation of neuroinflammation in the (PLP)-αsynuclein (αSYN) MSA model...
Animal models of multiple system atrophyNadia Stefanova
Clinical Department of Neurology, Innsbruck Medical University, 6020 Innsbruck, Austria
Trends Neurosci 28:501-6. 2005..Here, the currently available MSA animal models will be reviewed and leads for future research will be identified...
Investigation of autonomic function in idiopathic REM sleep behavior disorderBirgit Frauscher
Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
J Neurol 259:1056-61. 2012..Follow-up studies are needed to determine whether iRBD patients with dysfunction on several autonomic domains are at particular risk for developing one of these diseases...
Multiple system atrophy: an updateGregor K Wenning
Department of Neurology, University Hospital, Innsbruck, Austria
Mov Disord 18:S34-42. 2003..Several research groups have been formed in Europe (EMSA-SG, NNIPPS) and United States (NAMSA-SG), providing a framework for coordinated trial activity in MSA...
Assessing disease progression with MRI in atypical parkinsonian disordersMartin Köllensperger
Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 24:S699-702. 2009..The article reviews the current state of the art focusing on three atypical parkinsonian disorders: multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and dementia with Lewy bodies (DLB)...
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging conceptsLisa Fellner
Division of Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Austria
Acta Neuropathol 121:675-93. 2011..Finally, major therapeutic strategies targeting glial pathology in α-synucleinopathies as well as current pitfalls for disease-modification in clinical trials are discussed...
The role of alpha-synuclein in the pathogenesis of multiple system atrophyGregor K Wenning
Department of Neurology, University of Innsbruck, School of Medicine, Anichstrasse 35, 6020, Innsbruck, Austria
Acta Neuropathol (Berl) 109:129-40. 2005..Transgenic MSA mouse models are now available to determine these aspects of cellular disturbance experimentally...
Mortality in Parkinson's disease: a 20-year follow-up studyAnja Diem-Zangerl
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 24:819-25. 2009....
Genetic players in multiple system atrophy: unfolding the nature of the beastSylvia Stemberger
Division of Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Neurobiol Aging 32:1924.e5-14. 2011..In this review, we discuss the emerging evidence in favor of genetic players in MSA...
Social stigmatization in patients with cranial and cervical dystoniaMartina Rinnerthaler
Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
Mov Disord 21:1636-40. 2006..CCD patients are subject to serious prejudice and enacted stigmatization. There is a need for informing the public about the nature and symptoms of this disorder and a need to support patients to cope with stigmatization...
Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodiesChristian Brenneis
Department of Neurology, University Hospital of Innsbruck, Anichstr 35, 6020 Innsbruck, Austria
Neuroreport 15:1711-4. 2004..Atrophy of insular cortex was found in both patient groups...
An open trial of levetiracetam for segmental and generalized dystoniaSascha Hering
Department of Neurology, Medical University Innsbruck, Austria
Mov Disord 22:1649-51. 2007..At 4-week follow-up, none of the patients showed improvement of dystonia, mild side-effects were observed in 3 patients...
Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic studyCecilia Peralta
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
Mov Disord 21:1109-13. 2006..These results highlight the need for further prospective studies of the prevalence and underlying mechanisms of cardiac valvulopathy in PD patients treated with different dopamine agonists...
The role of alpha-synuclein and tau in neurodegenerative movement disordersGregor K Wenning
Department of Neurology, Medical University, Innsbruck, Austria
Curr Opin Neurol 18:357-62. 2005
Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndromeChristoph Schmidauer
Department of Neurology, Innsbruck Medical University, Austria
Ann Neurol 58:630-4. 2005..These findings lend further support to nigral iron deficiency as a pathogenetic factor in RLS...
Tumor necrosis factor-alpha-induced cell death in U373 cells overexpressing alpha-synucleinNadia Stefanova
Department of Neurology, University of Innsbruck, Innsbruck, Austria
J Neurosci Res 73:334-40. 2003..We conclude that alpha-synuclein overexpression significantly increases the vulnerability of U373 cells to apoptosis through TNF-alpha-mediated pathways...
Homocysteine and serum markers of immune activation in primary dystoniaUlf J Muller
University Hospital of Neurology, Medical University Innsbruck, Innsbruck, Austria
Mov Disord 20:1663-7. 2005..HCY is a neuronal excitotoxic amino acid and hyperhomocysteinemia is considered an independent vascular risk factor. Further studies are required to define the background of hyperhomocysteinemia in primary dystonia...
Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy)Nadia Stefanova
Department of Neurology, University Hospital of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
Acta Neuropathol 106:157-66. 2003..This suggests that complex integrative mechanisms are likely to regulate the vulnerability of the striatum and SNc to cell death in SND/MSA-P...
Huntington's disease: present treatments and future therapeutic modalitiesRaphael M Bonelli
University Clinic of Psychiatry, Karl Franzens University Graz, Graz University Clinic of Neurology, University of Innsbruck, Innsbruck, Austria
Int Clin Psychopharmacol 19:51-62. 2004..Finally, some cellular mechanisms are discussed in this paper because they are essential for future neuroprotective modalities, such as minocycline, unsaturated fatty acids or riluzole...
Placebo-controlled trial of amantadine in multiple-system atrophyGregor K Wenning
Department of Neurology, Innsbruck Medical University, Austria
Clin Neuropharmacol 28:225-7. 2005..Reports on the open-label use of amantadine in MSA suggest variable antiparkinsonian efficacy. The authors therefore conducted a double-blind, placebo-controlled crossover trial of amantadine in MSA patients...
Multiple system atrophyGregor K Wenning
Department of Neurology, University Hospital, A-6020 Innsbruck, Austria
Lancet Neurol 3:93-103. 2004..Symptomatic therapeutic strategies are still limited; however, several candidate neuroprotective agents have entered phase II and phase III clinical trials...
Atrophy pattern in SCA2 determined by voxel-based morphometryChristian Brenneis
Department of Neurology, University Hospital of Innsbruck, Innsbruck, Australia
Neuroreport 14:1799-802. 2003..Two mechanisms could contribute to the observed cortical atrophy. It could be either the result of primary supratentorial degeneration as part of the disease process and/or secondary atrophy due to cerebellar deafferentation...
Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's diseaseMichael F H Schocke
Department of Radiology, University of Innsbruck, Austria
Neuroimage 21:1443-51. 2004..Because rADCs in one direction are dependent on the slice orientation relative to the directions of fiber tracts, Trace(D) imaging appears to be more accurate in the separation of MSA-P from PD...
The Lewis family revisited: no evidence for autosomal dominant multiple system atrophyJose Berciano
Department of Neurology, University Hospital Marqués de Valdecilla UC, Santander, Spain
Parkinsonism Relat Disord 11:363-5. 2005..There remains no conclusive evidence to support the notion of hereditary MSA...
Lewy bodies in patients presenting clinically with Alzheimer diseaseKurt A Jellinger
Institute of Clinical Neurobiology, Vienna, Austria
J Alzheimers Dis 4:327-8. 2002
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's diseaseSilke Metzger
Department of Medical Genetics, University of Tubingen, Calwerstrasse 7, 72076 Tubingen, Germany
Neurogenetics 7:27-30. 2006..In this group, the allelic variation on locus S18Y is responsible for 1.1% of the variance in the HD age-at-onset, and the rare Y allele is associated with younger-aged cases...
Application of the International Cooperative Ataxia Scale rating in multiple system atrophyFrancois Tison
Federation de Neurologie, Epidémiologie et Biostatistiques Centre Hospitalo Universitaire de Bordeaux, Bordeaux, France
Mov Disord 17:1248-54. 2002..The ICARS appears a useful tool to extract and rate the severity of cerebellar signs in MSA; however, it is clearly contaminated by parkinsonian features...
Health-related quality of life in multiple system atrophyAnette Schrag
Department of Clinical Neurosciences, Royal Free and University College Medical School, London, United Kingdom
Mov Disord 21:809-15. 2006....
Grading of neuropathology in multiple system atrophy: proposal for a novel scaleKurt A Jellinger
Institute of Clinical Neurobiology, Vienna, Austria
Mov Disord 20:S29-36. 2005....
The 'risus sardonicus' of multiple system atrophyGregor K Wenning
Mov Disord 18:1211. 2003
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disordersIrene Litvan
Movement Disorder Program, University of Louisville, KY 40205, USA
Mov Disord 18:467-86. 2003..In each of these areas, diagnosis continues to rest on clinical findings and the judicious use of ancillary studies...
Genetic analysis of candidate genes modifying the age-at-onset in Huntington's diseaseSilke Metzger
Department of Medical Genetics, University of Tubingen, Calwerstrasse 7, 72076, Tubingen, Germany
Hum Genet 120:285-92. 2006..Although some of the factors have been defined as genetic modifier factors in previous studies, none of the genes encoding GRIK2, TBP, BDNF and ZDHHC17 could be identified as a genetic modifier for HD...
Survival in multiple system atrophyAnette Schrag
Department of Clinical Neurosciences, Royal Free and University College Medical School, London, United Kingdom
Mov Disord 23:294-6. 2008..49, 95% CI 0.97-2.31, P = 0.07). Except for rediagnosis as PD, no predictive factors for better survival could be identified. These data confirm the relatively poor prognosis of MSA of less than 9 years on average...
Olivopontocerebellar atrophy: toward a better nosological definitionJose Berciano
Service of Neurology, University Hospital Marques de Valdecilla, University of Cantabria, Santander, Spain
Mov Disord 21:1607-13. 2006..Our review suggests that the label "OPCA" is useful to designate a clinicopathological syndrome that has a variety of etiologies carrying a poor prognosis, particularly if associated with autonomic failure as occurs in MSA...
Disproportionate antecollis: a warning sign for multiple system atrophyFelix Geser
Mov Disord 22:1986; author reply 1986-7. 2007
Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's diseaseFrancois Tison
Federation de Neurologie, Epidémiologie et Biostatistiques Centre Hospitalo Universitaire de Bordeaux, Bordeaux, France
Mov Disord 17:701-9. 2002..It also indicates that the UPDRS-III provides a useful severity measure of parkinsonism in MSA, albeit contaminated by additional cerebellar dysfunction...
